Table 4.
Comparisons of the risk factors at registration between future cardiovascular event-free subjects (−) and subjects in whom cardiovascular events occurred (+)
| CVD(−) | CVD(+) | P | |
|---|---|---|---|
| All subjects | |||
| n | 706 | 82 | |
| Male, % | 63.1 | 73.2 | 0.073 |
| Age, yr | 61.4 ± 10.7 | 65.1 ± 9.8 | 0.003 |
| diabetes, % | 22.7 | 48.8 | <0.001 |
| history of CVDs, % | 22.1 | 45.1 | <0.001 |
| BMI, kg/m2 | 21.2 ± 3.2 | 21.4 ± 3.3 | 0.48 |
| albumin, g/dl | 3.66 ± 0.30 | 3.63 ± 0.33 | 0.61 |
| systolic BP, mmHg | 151.9 ± 22.1 | 158.4 ± 21.9 | 0.013 |
| Diastolic BP, mmHg | 76.3 ± 9.9 | 75.6 ± 9.8 | 0.53 |
| non-HDL cholesterol (mmol/L) | 2.93 ± 0.87 | 3.11 ± 0.96 | 0.080 |
| HDL cholesterol, mmol/L | 1.20 ± 0.37 | 1.13 ± 0.36 | 0.100 |
| high fatigue score, % | 13.4 | 26.7 | 0.006 |
| Well-nourished subjects (albumin >3.3) without diabetes and history of CVDs | |||
| n | 338 | 15 | |
| male, % | 59.5 | 53.3 | 0.63 |
| age, yr | 60.0 ± 10.9 | 65.5 ± 13.3 | 0.055 |
| BMI, kg/m2 | 20.8 ± 3.2 | 20.6 ± 2.8 | 0.77 |
| systolic BP, mmHg | 149.6 ± 22.3 | 151.5 ± 20.3 | 0.74 |
| diastolic BP, mmHg | 76.3 ± 9.3 | 77.0 ± 9.7 | 0.77 |
| non-HDL cholesterol, mmol/L | 2.90 ± 0.86 | 3.13 ± 0.96 | 0.30 |
| HDL cholesterol, mmol/L | 1.23 ± 0.37 | 1.24 ± 0.32 | 0.92 |
| high fatigue score, % | 13.9 | 36.4 | 0.039 |
Well-nourished subjects were determined by serum albumin level higher than 3.3g/dl which was determined as higher than mean minus 1 standard deviation. CVD, events for cardiovascular diseases; HDL, high density lipoprotein.